1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib.
Du C, Mao X, Xu Y, Yan Y, Yuan C, Du X, Liu J, Fan H, Wang Q, Sui W, Deng S, Fu M, Li Z, Li C, Zhao J, Yi S, Liu L, Hao M, Zou D, Zhao Y, Qiu L, An G.
Du C, et al. Among authors: liu j, liu l.
Leuk Lymphoma. 2020 May;61(5):1201-1210. doi: 10.1080/10428194.2019.1700503. Epub 2019 Dec 16.
Leuk Lymphoma. 2020.
PMID: 31842644
Clinical Trial.